01 Gemini PharmChem Mannheim GmbH (1)
02 Japan Micro Biopharma Co., Ltd. (1)
03 Meiji Seika Pharma Co., Ltd. (2)
04 Olon S. p. A. (1)
05 Zhejiang Hisun Pharmaceutical Co. , Ltd. (1)
01 Day stations doxorubicin hydrochloride (1)
02 Doxorubicin Hydrochloride (3)
03 Doxorubicin hydrochloride (2)
01 China (1)
02 Germany (1)
03 Italy (1)
04 Japan (3)
63
PharmaCompass offers a list of Doxorubicin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Doxorubicin Hydrochloride API Price utilized in the formulation of products. Doxorubicin Hydrochloride API Price is not always fixed or binding as the Doxorubicin Hydrochloride Price is obtained through a variety of data sources. The Doxorubicin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tox21_202483 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_202483, including repackagers and relabelers. The FDA regulates Tox21_202483 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_202483 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tox21_202483 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tox21_202483 supplier is an individual or a company that provides Tox21_202483 active pharmaceutical ingredient (API) or Tox21_202483 finished formulations upon request. The Tox21_202483 suppliers may include Tox21_202483 API manufacturers, exporters, distributors and traders.
click here to find a list of Tox21_202483 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tox21_202483 Drug Master File in Japan (Tox21_202483 JDMF) empowers Tox21_202483 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tox21_202483 JDMF during the approval evaluation for pharmaceutical products. At the time of Tox21_202483 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tox21_202483 suppliers with JDMF on PharmaCompass.
We have 5 companies offering Tox21_202483
Get in contact with the supplier of your choice: